Skip to main content
. 2023 Feb 12;15(4):1173. doi: 10.3390/cancers15041173

Table 2.

Comparison of different localization methods used in breast cancer patients undergoing breast conserving surgery (modified after: [26].

Advantages Disadvantages
Wire-guided localization (WGL)
  • Well-established

  • Cost-effective

  • Marker placement under radiographic, ultrasound or MRI guidance possible suitable for localization of lesions visible only upon mammography (e.g., microcalcifications) or MRI

  • Control mammogram or MRI after wire placement possible

  • Reposition in case of some wires possible

  • Scheduling issues: the wire needs to be placed on the day of surgery or the day before

  • Wire dislocation possible

  • Patient discomfort

Radioactive seed localization (RSL)
  • Well-established

  • Scheduling flexibility: localization can be performed several days/weeks before surgery or—in case of neoadjuvant therapy—before start of treatment

  • Marker placement under radiographic or ultrasound guidance possible suitable for localization of lesions visible only upon mammography (e.g., microcalcifications)

  • Control mammogram after marker placement possible

  • Can be combined with isotope-based sentinel node biopsy

  • Procedure not authorized in some countries, requires complex radiation safety procedures

  • Radiation exposure to patient and staff

  • Invasive procedure for marker placement necessary

  • In case of marker placement before neoadjuvant therapy signal loss possible in case of longer than planned duration of therapy

  • Reposition after placement not possible

  • Radiation safety concerns regarding MRI-guided localization (Geiger counter is MRI unsafe and cannot be used in case of seed loss in Zone IV)

  • Very low risk of seed rupture or transection, resulting in emergency treatment with iodine to saturate and safeguard the thyroid gland in case of 125I

Radio-guided Occult Lesion Localization (ROLL)
  • Well-established

  • Marker placement under radiographic, ultrasound or MRI guidance possible suitable for localization of lesions visible only upon mammography (e.g., microcalcifications) or MRI

  • Scheduling issues: procedure needs to be performed on the day of surgery or the day before

  • Radiation safety procedures required

  • Potential radiation exposure to patient and staff

  • Invasive preoperative procedure necessary

  • Reposition after placement not possible

  • Control mammogram not possible unless contrast also given

Magnetic and paramagnetic localization
Commercially available systems:
  • Magseed (Endomag)

  • Sirius Pintuition (formerly known as MaMaLoc; Sirius Medical)

  • MOLLI (MOLLI Surgical)

  • TAKUMI/Guiding-marker system (Hakko)

  • No radioactivity involved

  • Marker placement under radiographic or ultrasound guidance possible suitable for localization of lesions visible only upon mammography (e.g., microcalcifications)

  • Scheduling flexibility: localization can be performed several days/weeks before surgery or—in case of neoadjuvant therapy—before start of treatment

  • No decrease of signal over time reliable detectability in case of longer than planned neoadjuvant therapy

  • Control mammogram after marker placement possible

  • Can be combined with magnetic tracer for sentinel node biopsy

  • Concerns regarding use in patients with pacemakers and implantable defibrillators

  • Standard metal surgical tools may lead to interference during measurement

  • Large MRI artifacts

  • Not suitable for lesions visible only upon MRI

  • Higher device cost

  • Adequate localization may be limited in case of a large distance between marker and detection probe

  • Reposition after placement not possible

Radar reflector-based localization
Commercially available systems:
  • SAVI SCOUT (Merit Medical)

  • No radioactivity involved

  • Minimal MRI artifact

  • Marker placement under radiographic or ultrasound guidance possible suitable for localization of lesions visible only upon mammography (e.g., microcalcifications)

  • Scheduling flexibility: localization can be performed several days/weeks before surgery or—in case of neoadjuvant therapy—before start of treatment

  • No decrease of signal over time reliable detectability in case of longer than planned neoadjuvant therapy

  • Control mammogram after marker placement possible

  • Potential signal interference with lights in the operating theatre

  • Small MRI artifacts

  • Not suitable for lesions visible only upon MRI

  • Higher device cost

  • Adequate localization may be limited in case of a large distance between marker and detection probe

  • Reposition after placement not possible

Radiofrequency identification tags (RFID)
Commercially available systems:
  • LOCalizer (HOLOGIC)

  • EnVisio (Elucent Medical)

  • No radioactivity involved

  • Scheduling flexibility: localization can be performed several days/weeks before surgery or—in case of neoadjuvant therapy—before start of treatment

  • Marker placement under radiographic or ultrasound guidance possible suitable for localization of lesions visible only upon mammography (e.g., microcalcifications)

  • No decrease of signal over time reliable detectability in case of longer than planned neoadjuvant therapy

  • Unique tag number differentiation between tags possible

  • Control mammogram after marker placement possible

  • Concerns regarding use in patients with pacemakers and implantable defibrillators

  • MRI artifacts

  • Not suitable for lesions visible only upon MRI

  • Higher device cost

  • Adequate localization may be limited in case of a large distance between marker and detection probe

  • Reposition after placement not possible

Intraoperative ultrasound (IOUS)
  • Direct visualization during surgery

  • No radioactivity involved

  • Patient friendly (non-invasive)

  • No preoperative invasive procedure necessary scheduling flexibility

  • Specimen sonography is performed immediately after tissue removal no time loss due to specimen transport

  • Specimen sonography performed in the operating room exact and reliable topographic localization of close margins for immediate re-excision

  • Relatively low cost

  • Surgeon needs to be experienced in breast ultrasound, otherwise radiologist’s presence in the operating theatre necessary

  • Learning curve

  • Useful only for lesions with good sonographic visibility

  • Not suitable for lesions visible only upon mammography (e.g., microcalcifications) or MRI

  • Use in the neoadjuvant setting limited in case of complete remission due to low sonographic visibility of some tissue markers

  • Ultrasound machine must be available in the operating theatre during surgery

  • Some ultrasound machines available in operating theatres are unsuitable for breast ultrasound (frequency, transducer type) or of a much lower quality than machines in the diagnostics department

  • Radiogram showing lesion and marker not possible

Carbon
  • No radioactivity involved

  • Low cost

  • Scheduling flexibility: localization can be performed several days/weeks before surgery or—in case of neoadjuvant therapy—before start of treatment

  • Marker placement under radiographic or ultrasound guidance possible

  • No MRI artifacts

  • Marker cannot be localized without surgical exploration

  • Possible ink migration

  • Intentional or unintentional tattooing of skin

  • Reposition after placement not possible

  • Control mammogram not possible